New Insights in Viral Diseases and Computational Biology

Dear Colleagues,

Humanity and animality are facing threats from various viruses, including RNA viruses such as SARS-CoV-2, the influenza virus, the respiratory syncytial virus (RSV), and the Ebola virus. SARS-CoV-2, influenza virus, and respiratory syncytial virus all cause acute respiratory viral infections. As of August 2023, the World Health Organization (WHO) had reported over 769 million confirmed cases of COVID-19 and approximately 6.95 million confirmed deaths. The overlap of SARS-CoV-2 with seasonal epidemics of RSV and influenza viruses has also resulted in significant morbidity and mortality among young children worldwide [1]. Although Ebola virus outbreaks have been mainly restricted to Africa, they have resulted in much higher fatality rates, with an average of around 50%.

Bioinformatics approaches, employing vast new technologies, have been widely used to address research questions regarding virus evolution and host responses. Second- and third-generation sequencing have provided large amounts of resource data for bioinformatics analysis, aiding in the understanding of the biology of both the virus and its infected host.

In the form of a Special Issue, our aim is to provide a collection of the most recent top research articles, comprehensive reviews, as well as short communications in line with computational virus biology. Through this Special Issue, we aim to pinpoint our efforts towards understanding the infection biology of viruses using various bioinformatics approaches.

I am looking forward to your valuable involvement in this interesting Special Issue.

Reference:

1. Steponavičienė, A.; Burokienė, S.; Ivaškevičienė, I.; Stacevičienė, I.; Vaičiūnienė, D.; Jankauskienė, A. Influenza and Respiratory Syncytial Virus Infections in Pediatric Patients during the COVID-19 Pandemic: A Single-Center Experience. Children 2023, 10, 126.

Dr. Xiaofeng Dong
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pathogens is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.